Meticulous Research®—a leading market research company, published a research report titled, ‘IVD Quality Control Market Size, Share, Forecast & Trends Analysis by Offering (Product [Serum, Blood], Data Management, Service) Technology (Biochemistry, Molecular, Immunoassay) Application (cardiology, Oncology) End User – Global Forecast to 2031’
Download Free Sample Report@ https://www.meticulousresearch.com/download-sample-report/cp_id=3447?utm_source=blog&utm_medium=social&utm_campaign=product&utm_content=24-10-2024
The latest publication from Meticulous Research® forecasts that the global IVD quality control market will reach $2.28 billion by 2031, with a compound annual growth rate (CAGR) of 4.3% from 2024 to 2031. Factors driving this growth include the rising prevalence of chronic illnesses, an aging global population, increased demand for third-party quality controls, and the need for more extensive internal and external quality assessments in laboratories. The market is also benefiting from the growing demand for Point-of-Care (POC) diagnostics and rapid testing.
Opportunities in the market arise from the increased demand for multi-instrument and multi-analyte quality controls, though regulatory complexities and a lack of access to quality assurance materials remain challenges.
Key players in the market include Siemens Healthineers AG (Germany), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), and others. The immunoassay/immunochemistry segment is expected to dominate the market by 2024 due to its high sensitivity and cost-effectiveness. The infectious diseases application segment is projected to hold the largest market share, driven by the high incidence of diseases like HIV and COVID-19.
In terms of end-users, hospitals and clinics are anticipated to account for the largest market share due to the high volume of diagnostic tests and growing healthcare infrastructure. The Asia-Pacific region is poised to experience the fastest growth, fueled by rising healthcare spending, expanding hospital networks, and increased demand for early diagnostic testing.
About Meticulous Research®:
Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.
Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Comments on “IVD Quality Control Industry to Achieve $2.28 Billion Milestone by 2031”